Edoxaban 
Daiichi Sankyo
['edoxaban', 'warfarin']
in an #engage af-timi 58 analysis of pts 80 years with afib, showed that pts randomized to #edoxaban 30mg experienced similar rates of sse but less bleeding, net outcomes, &amp; all-cause death vs. warfarin, regardless of dose-reduction criteria. #acc23 
Providing the latest news and research from the TIMI Study Group, an ARO affiliated with Brigham and Women’s Hospital and Harvard Medical School.